AGEN

Agenus News

Kaufen
Verkaufen
Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Agenus Inc AGEN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,01 -0,51% 1,95 11:04:22
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,96
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.7.202215:15TRMNWilliam Blair Thinks Agenus’ Stock is Going to Recover
30.6.202214:30GLOBEAgenus to Participate at William Blair’s Biotech Focus..
29.6.202213:00GLOBEAgenus Shows Unprecedented Activity for..
21.6.202214:30GLOBEAgenus to Host Investor Webcast to Review Late-Breaking..
14.6.202222:07EDGARCurrent Report Filing (8-k)
10.6.202217:15TRMNB.Riley Financial Thinks Agenus’ Stock is Going to Recover
10.6.202214:00GLOBEGSK’s RSV vaccine candidate for older adults, containing..
09.6.202222:06EDGARProxy Statement - Notice of Shareholders Meeting..
31.5.202214:30GLOBEAgenus Advances Portfolio with 6 Clinical Collaborations
25.5.202214:30GLOBEAgenus to Participate at Jefferies Healthcare Conference
24.5.202214:30GLOBEAgenus Announces Late-Breaking Oral Presentation at ESMO-GI..
10.5.202214:02EDGARCurrent Report Filing (8-k)
10.5.202214:00GLOBEAgenus Corporate Update and First Quarter 2022 Financial..
26.4.202214:30GLOBEAgenus to Provide Corporate Update and First Quarter 2022..
13.4.202213:45TRMNB.Riley Financial Thinks Agenus’ Stock is Going to Recover
08.4.202222:35EDGARStatement of Ownership (sc 13g)
08.4.202219:00GLOBEAgenus Presents Data on AGEN1571 (anti-ILT2) at AACR and..
06.4.202200:40EDGARStatement of Changes in Beneficial Ownership (4)
06.4.202200:35EDGARStatement of Changes in Beneficial Ownership (4)
06.4.202200:27EDGARStatement of Changes in Beneficial Ownership (4)
06.4.202200:24EDGARStatement of Changes in Beneficial Ownership (4)
05.4.202214:30GLOBEAgenus’ CD137 Agonist (AGEN2373) Advances in the Clinic,..
07.3.202213:40SEEKAgenus, Targovax team up for mutant KRAS cancer vaccines
07.3.202213:00GLOBETargovax ASA and Agenus announce collaboration on mutant..
01.3.202214:16EDGARCurrent Report Filing (8-k)
01.3.202214:13SEEKAgenus GAAP EPS of -$0.26 misses by $0.10, revenue of..
01.3.202214:00GLOBEAgenus Corporate Update and Fourth Quarter & Full Year 2021..
01.3.202213:37EDGARAnnual Report (10-k)
28.2.202217:54SEEKAgenus Q4 2021 Earnings Preview
15.2.202214:30GLOBEAgenus to Provide Corporate Update and Fourth Quarter & Full..
11.2.202222:10EDGARAmended Statement of Ownership (sc 13g/a)
11.2.202222:01EDGARAmended Statement of Ownership (sc 13g/a)
10.2.202222:52EDGARStatement of Ownership (sc 13g)
09.2.202221:20EDGARAmended Statement of Ownership (sc 13g/a)
09.2.202200:16EDGARStatement of Changes in Beneficial Ownership (4)
09.2.202200:15EDGARStatement of Changes in Beneficial Ownership (4)
09.2.202200:11EDGARStatement of Changes in Beneficial Ownership (4)
09.2.202200:10EDGARStatement of Changes in Beneficial Ownership (4)
09.2.202200:10EDGARStatement of Changes in Beneficial Ownership (4)
04.2.202223:51EDGARStatement of Changes in Beneficial Ownership (4)
04.2.202223:51EDGARStatement of Changes in Beneficial Ownership (4)
04.2.202223:50EDGARStatement of Changes in Beneficial Ownership (4)
06.1.202223:29EDGARCurrent Report Filing (8-k)
05.1.202221:26EDGARStatement of Changes in Beneficial Ownership (4)
05.1.202221:24EDGARStatement of Changes in Beneficial Ownership (4)
05.1.202221:11EDGARStatement of Changes in Beneficial Ownership (4)
05.1.202220:59EDGARStatement of Changes in Beneficial Ownership (4)
05.1.202214:30GLOBEAgenus to Participate at Upcoming Investor Conferences
05.1.202200:44EDGARStatement of Changes in Beneficial Ownership (4)
04.1.202213:41TRMNAgenus (AGEN) Gets a Buy Rating from William Blair
Kürzlich von Ihnen besucht
NASDAQ
AGEN
Agenus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20220705 09:22:26